Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human DYRK3 Stable Cell Line

    [CAT#: S01YF-1123-KX220]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Kinase Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Based on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.

    Sub Cat Product Name Target Protein Species Host Cell Type Assay Types Inquiry Datasheet
    S01YF-1122-KX1107 Magic™ Human DYRK3 in Vitro Assay Human Kinase Assay

    Product Information

    Target Protein
    DYRK3
    Target Family
    Kinases/Enzyme Drug Discovery Assays and Products
    Target Protein Species
    Human
    Host Cell Type
    CHO-K1; HEK293
    Target Classification
    Kinase Cell Lines
    Target Research Area
    CNS Research; Reproductive Research
    Related Diseases
    Neuroaspergillosis and Intellectual Developmental Disorder, Autosomal Dominant 7
    Gene ID
    UniProt ID

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    The enzyme known as dual specificity tyrosine-phosphorylation-regulated kinase 3 is encoded by the DYRK3 gene in humans. The DYRK family of dual-specificity protein kinases, which includes this gene product, catalyzes autophosphorylation on tyrosine and serine/threonine residues. Despite having comparable structural features, the members of this family have varied substrate specificities, which may indicate that they are involved in various cellular processes. It has been demonstrated that the encoded protein can catalyze the phosphorylation of histones H3 and H2B in vitro and autophosphorylate on tyrosine residues. Different isoforms are encoded by alternatively spliced transcript variants that have been discovered. The customized DYRK3 stable cell line can be used in antibody discovery and development, potential drug candidate screening and signaling pathway researches.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    chat Carol

    The DYRK3 cell line was delivered promptly, and it performed exceptionally well in my assays. Jul 30 2021

    chat Verified Customer

    chat Charles

    The DYRK3 cell line is easy to handle and has shown consistent performance in various experimental setups. Oct 26 2021

    chat Verified Customer

    FAQ

    Any questions about our products? Please visit our frequently asked questions page.

    Published Data

    Fig.1 DYRK3 phosphorylates SNAPIN at the threonine 14 residue.

    Following a 24-hour transfection of HEK293 cells with a plasmid encoding Myc-SNAPIN, three identical cell lysates were subjected to immunoprecipitation using an anti-Myc antibody. Through immunoblotting with an anti-Myc antibody, the correct expression of transiently produced SNAPIN in cell extracts was confirmed (Input).

    Ref: Lee, Ye Hyung, et al. "DYRK3 phosphorylates SNAPIN to regulate axonal retrograde transport and neurotransmitter release." Cell Death Discovery 8.1 (2022): 503.

    Pubmed: 36585413

    DOI: 10.1038/s41420-022-01290-0

    Research Highlights

    By controlling the activity of a crucial enzyme involved in condensate disintegration and translation restoration, Hsp90 establishes a connection between stress adaption and cell development.
    Mediani, Laura, et al. "Hsp90-mediated regulation of DYRK3 couples stress granule disassembly and growth via mTORC1 signaling." EMBO reports 22.5 (2021): e51740.
    Pubmed: 33738926   DOI: 10.15252/embr.202051740

    The prognosis for patients with glioblastoma multiforme (GBM), a malignant primary brain tumor, is not good. Even though surgery, chemotherapy, and radiation therapy are the usual treatments for gastric cancer of the breast (GBM), a tiny percentage of tumor cells that survive develop resistance to treatment and become more aggressive.
    Kim, Kyeongmin, et al. "Dual specificity kinase DYRK3 promotes aggressiveness of glioblastoma by altering mitochondrial morphology and function." International Journal of Molecular Sciences 22.6 (2021): 2982.
    Pubmed: 33804169   DOI: 10.3390/ijms22062982

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare